CONKLIN, JON – Trademark Portfolio
Entity Type: 01
CONKLIN, JON holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include CITRAQUIN, EQUIBRACE, DRAW IT OUT, RESTOREAHORSE, and RESTORE A HORSE. The owner is based in MENDON, UT.
520 SOUTH 5750 WEST
MENDON, UT 84325
Showing of trademarks Trademarks
Trademark Classifications
CONKLIN, JON's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does CONKLIN, JON have?
CONKLIN, JON has 12 U.S. trademarks filed with the USPTO. Of these, 8 registered, 3 abandoned, 1 cancelled.
What trademark classes does CONKLIN, JON file in?
CONKLIN, JON files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CONKLIN, JON's most well-known trademarks?
CONKLIN, JON's registered trademark portfolio includes well-known marks such as CITRAQUIN, EQUIBRACE, DRAW IT OUT, RESTOREAHORSE, and RESTORE A HORSE. These are among 8 currently registered trademarks in the portfolio.
What is CONKLIN, JON's trademark registration success rate?
CONKLIN, JON has a 67% trademark registration rate, with 8 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.